J Korean Med Assoc.  2005 Mar;48(3):236-246. 10.5124/jkma.2005.48.3.236.

Urologic Disease in Elderly Men

• Lee CH

• KMID: 1723896
• DOI: http://doi.org/10.5124/jkma.2005.48.3.236

Abstract

No abstract available.

Keyword

Guideline; Benign prostatic hyperplasia; Erectile dysfunction; Aging male

MeSH Terms

Aged*
Erectile Dysfunction
Humans
Male
Prostatic Hyperplasia
Urologic Diseases*

Figure

• 

  Figure 1

Reference

2. Zakaria L, Anastasiadis AG, Shabsigh R. Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression. Int Urol Nephrol. 2001. 33:283–292.

4. AUA practice guideline committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003. 170:530–547.

5. Roehrborn CG, Malice M, Cook TJ, Girman CJ. Clinical predictors of spontaneous acute retention in man with LUTS and clinical BPH: a comprehensive analysis of pooles placebo broups of several large clinical trials. Urology. 2001. 58:210–216.

6. Lam JS, Cooper KL, Kaplan SA. Changing aspects in the evaluation and treatment of patient with benign prostatic hyperplasia. Med Clin N Am. 2004. 88:281–308.

7. Lepor H, Lowe FC. Walsh PC, Retic AB, Vauhgan ED, Wein AJ, editors. Evaluation and nonsurgical management of benign prostatic hyperplasia. Campbell's urology. 2002. 8th ed. Philadelphia: WB Saunders;1337–1378.

8. Feldman HA, Goldstein I, Hatzichiristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994. 151:54–61.

9. Krane RJ, Goldstein I, Saenz De Tajada I. Medical progress: impotence. N Engl J Med. 1989. 321:1648–1653.

10. Goldstein I, Leu TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998. 338:1397–1404.

11. Sharaby JS, Benet AE, Melman A. Penile revascularization: impotence. Urol Clin North Am. 1995. 22:699–709.

12. Wespes W, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y. Guidelines on erectile dysfunction. Eur Urol. 2002. 41:1–5.

13. Leiblum SR, Rosen RC, Platt M, Cross RC, Black C. Sexual attitudes and behavior of a cross-sectional samples of US medical students: effect gender, age, and year of study. J Sex Educ Ther. 1993. 19:235.

14. Meuleman EJ, Diemont WL. Investigation of erectile dysfunction: diagnostic testing for vascular factor in erectile dysfunction: impotence. Urol Clin North Am. 1995. 22:803–819.

15. Broderick GA, Lue TF. Walsh PC, Retic AB, Vauhgan ED, Wein AJ, editors. Evaluation and nonsurgical management of erectile dysfunction and priapism. Campbell's urology. 2002. 8th ed. Philadelphia: WB Saunders;1619–1671.

16. Kalsi JS, Cellek S, Munneer A, Kell PD, Ralph DJ, Minhas S. Current oral treatemnt for erectile dysfunction. Expert Opin Pharmacother. 2002. 3:1513–1529.

17. Corbin JD, Francis SH, Webb DJ. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology. 2002. 60:Suppl 2B. 4–11.